Cordycepin regulates GSK-3β/β-catenin signaling in human leukemia cells.
Leukemia stem cells (LSCs) are a limitless cell source for the initiation and maintenance of leukemia. Activation of the Wnt/β-catenin pathway is required for the survival and development of LSCs. Therefore, targeting β-catenin is considered a therapeutic strategy for the treatment of leukemia. The...
Main Authors: | Bor-Sheng Ko, Yi-Jhu Lu, Wen-Ling Yao, Tzu-An Liu, Shean-Shong Tzean, Tang-Long Shen, Jun-Yang Liou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3784440?pdf=render |
Similar Items
-
14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3β.
by: Tzu-Ching Chang, et al.
Published: (2012-01-01) -
Adenosine and Cordycepin Accelerate Tissue Remodeling Process through Adenosine Receptor Mediated Wnt/β-Catenin Pathway Stimulation by Regulating GSK3b Activity
by: Jaeyoon Kim, et al.
Published: (2021-05-01) -
GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer
by: Richard L. Watson, et al.
Published: (2010-05-01) -
ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
by: A. S. Kulakova, et al.
Published: (2021-10-01) -
Destabilization of Heterologous Proteins Mediated by the GSK3β Phosphorylation Domain of the β-Catenin Protein
by: Yuhan Kong, et al.
Published: (2013-11-01)